Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study.
about
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lower risk of dementia with pi ...... tion-based longitudinal study.
@en
Lower risk of dementia with pi ...... tion-based longitudinal study.
@nl
type
label
Lower risk of dementia with pi ...... tion-based longitudinal study.
@en
Lower risk of dementia with pi ...... tion-based longitudinal study.
@nl
prefLabel
Lower risk of dementia with pi ...... tion-based longitudinal study.
@en
Lower risk of dementia with pi ...... tion-based longitudinal study.
@nl
P2093
P2860
P1433
P1476
Lower risk of dementia with pi ...... tion-based longitudinal study.
@en
P2093
Chen-Yi Yang
Cheng-Yang Hsieh
Chieh-Hsiang Lu
Huang-Tz Ou
P2860
P2888
P304
P356
10.1007/S00125-017-4499-5
P50
P577
2017-11-14T00:00:00Z